Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study
NCT ID: NCT04872699
Last Updated: 2021-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2021-04-22
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
NOsocomial Dissemination Risk of SARS-Cov2
NCT04339881
Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital
NCT04362267
Prevalence of COVID-19 Infection Among HCW in a French University Hospital
NCT04371692
Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps
NCT04695457
2-year Mortality After COVID-19 in Nursing Home Residents
NCT06468761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These observations have led the French government to establish specific protection measures and survey dependent care facilities for the elderly and long-term care units in the hospital.
With these new standards established, a long-term study of all the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), can provide additional knowledge on COVID-19.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serology testing, RT PCR
Periodic testings and testings with characteristic symptoms occur
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* inpatients of the long-term care unit
* from march, 2020 to december, 2021
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Sud Essonne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shidasp SIAMI, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Sud Essonne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sud Essonne
Étampes, Essonne, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPEED-COVID19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.